Emerging new drugs for wound repair

Bibliography

• MUSTOE TA: Understanding chronic wounds: a unifying hypothesis on their pathogenesis and implications for therapy. Am. J. Surg. (2004) 187(5):65S-70S.
   PubMed Web of Science ®Google Scholar
• CROSS KJ, MUSTOE TA: Growth factors in wound healing. Surg. Clin. N. Am. (2003) 83(3):531-545.
   PubMed Web of Science ®Google Scholar
• GORTI GK, KOCH RJ: Modulation of wound healing and scar formation. Curr. Opin. Otolaryngol. Head Neck Surg. (2002) 10:287-291.
   Google Scholar
• PIERCE GF, MUSTOE TA: Pharmacologic enhancement of wound healing. Ann. Rev. Med. (1995) 46:467-481.
   PubMed Web of Science ®Google Scholar
• BRIGHAM PA, MCLOUGHLIN E: Burn incidence and medical care use in the United States: estimates, trends, and data sources. J. Burn Care Rehab. (1996) 17(2):95-107.
   PubMedGoogle Scholar
• LIMOVA M: New therapeutic options for chronic wounds. Derm. Clin. (2002) 20(2):357-363.
   PubMed Web of Science ®Google Scholar
• PETRIE NC, YAO F, ERIKSSON E: Gene therapy in wound healing. Surg. Clin. N. Am. (2003) 83(3):597-616.
   PubMed Web of Science ®Google Scholar
• HERRICK SE, SLOAN P, MCGURK M, FREAK L, MCCOLLUM CN, FERGUSON MW: Sequential changes in histologic pattern and extracellular matrix deposition during the healing of chronic venous ulcers. Am. J. Path. (1992) 141(5):1085-1095.
   PubMed Web of Science ®Google Scholar
• THOMAS DR, GOODE PS, TARQUINE PH, ALLMAN RM: Hospital-acquired pressure ulcers and risk of death. J. Am. Geriatr. Soc. (1996) 44(12):1435-1440.
   PubMed Web of Science ®Google Scholar
• MECHANICK JI: Practical aspects of nutritional support for wound-healing patients. Am. J. Surg. (2004) 188(1A Suppl.):52-56.
   PubMed Web of Science ®Google Scholar
• COLLINS N: The right mix: using nutritional interventions and an anabolic agent to manage a stage IV ulcer. Adv. Skin Wound Care (2004) 17(1):36,38-39.
   PubMedGoogle Scholar
• FOSTER RD, ANTHONY JP, MATHES SJ, HOFFMAN WY: Ischial pressure sore coverage: a rationale for flap selection. Br. J. Plast. Surg. (1997) 50:374-379.
   PubMedGoogle Scholar
• SORENSEN JL, JORGENSEN B, GOTTRUP F: Surgical treatment of pressure ulcers. Am. J. Surg. (2004) 188(1A Suppl.):42-51.
   PubMed Web of Science ®Google Scholar
• LEVENSON SM, GRUBER DK, GRUBER C: Chemical debridement of burns: mercaptans. J. Trauma (1981) 21:632-644.
   PubMed Web of Science ®Google Scholar
• BURKE JF, GOLDEN TA: A clinical evaluation of enzymatic debridement with papain-urea-chlorophyllin ointment. Am. J. Surg. (1958) 95:828-842.
   PubMed Web of Science ®Google Scholar
• LEVINE N, SEIFTER E, CONNERTON C, LEVENSON SM: Debridement of experimental skin burns of pigs with bromelain, a pineapple-stem enzyme. Plast. Reconstr. Surg. (1973) 52:413-424.
   PubMed Web of Science ®Google Scholar
• LEVENSON SM: Supportive therapy in burn care. Debriding agents. J. Trauma (1979) 19:928-930.
   PubMedGoogle Scholar
• RAO DB, SANE PG, GEORGIEV EL: Collagenase in the treatment of dermal and decubitus ulcers. J. Am. Geriatr. Soc. (1975) 1:22-30.
   Google Scholar
• HANSBROUGH JF, ACHAUER B, DAWSON J: Wound healing in partial-thickness burn wounds treated with collagenase ointment versus silver sulfadiazine cream. J. Burn Care Rehab. (1995) 16:241-247.
   PubMedGoogle Scholar
• OZCAN C, ERGUN O, CELIK A, CORUK N, OZOK G: Enzymatic debridement of burn wounds with collagenase in children with partial-thickness burns. Burns (2002) 28(8):791-794.
   PubMed Web of Science ®Google Scholar
• ALVAREZ OM, FERNANDEZ-OBREGON A, ROGERS RS, BERGAMO L, MASSO J, BLACK M: A prospective, randomized, comparative study of collagenase and papain-urea for pressure ulcer debridement. Wounds (2002) 14(8):293-301.
   Web of Science ®Google Scholar
• ROSENBERG L, LAPID O, BOGDANOV-BEREZOVSKY A et al.: Safety and efficacy of a proteolytic enzyme for enzymatic burn debridement: a preliminary report. Burns (2004) 30(8):843-850.
   PubMed Web of Science ®Google Scholar
• HOPF HW, HUNT TK, WEST JM: Wound tissue oxygen tension predicts the risk of wound infection in surgical patients. Arch. Surg. (1997) 132:997-1005.
   PubMed Web of Science ®Google Scholar
• ARGENTA LC, MORYKWAS MJ: Vacuum-assisted closure: a new method for wound control and treatment: clinical experience. Ann. Plast. Surg. (1997) 38(6):563-576.
   PubMed Web of Science ®Google Scholar
• MORYKWAS MJ, ARGENTA LC, SHELTON-BROWN EI: Vacuum-assisted closure: a new method for wound control and treatment: animal studies and basic foundation. Ann. Plast. Surg. (1997) 38(6):553-562.
   PubMed Web of Science ®Google Scholar
• MOISIDIS E, HEATH T, BOORER C, HO K, DEVA AK: A prospective, blinded, randomized, controlled clinical trial of topical negative pressure use in skin grafting. Plast. Reconstr. Surg. (2004) 114(4):917-922.
   PubMed Web of Science ®Google Scholar
• GENECOV DG, SCHNEIDER AM, MORYKWAS MJ, PARKER D, WHITE WL, ARGENTA LC: A controlled subatmospheric pressure dressing increases the rate of skin graft donor site reepithelialization. Ann. Plast. Surg. (1998) 40(3):219-225.
   PubMed Web of Science ®Google Scholar
• EVANS D, LAND L: Topical negative pressure for treating chronic wounds: a systematic review. Br. J. Plast. Surg. (2001) 54(3):238-242.
   PubMedGoogle Scholar
• JOSEPH E, HAMORI CA, BERGMAN S, ROAF E, SWANN NF, ANASTASI GW: A prospective, randomized trial of vacuum-assisted closure versus standard therapy of chronic non-healing wounds. Wounds (2000) 12(3):60-67.
   Web of Science ®Google Scholar
• HEGGERS J, GOODHEART RE, WASHINGTON J et al.: Therapeutic efficacy of three silver dressings in an infected animal model. J. Burn Care Rehab. (2005) 26(1):53-56.
   PubMedGoogle Scholar
• O’CONNOR NE, MULLIKEN JB, BANKS-SCHLEGEL S, KEHINDE O, GREEN H: Grafting of burns with cultured epithelium prepared from autologous epidermal cells. Lancet (1981) 1:75-78.
   PubMed Web of Science ®Google Scholar
• SHERIDAN RL, THOMPKINS RG: Cultured autologous epithelium in patients with burns of ninety percent or more of the body surface. J. Trauma (1995) 38(1):48-50.
   PubMed Web of Science ®Google Scholar
• ELDAD A, BURT A, CLARKE JA, GUSTERSON B: Cultured epithelium as a skin substitute. Burns (1987) 13(3):173-180.
   Web of Science ®Google Scholar
• BALASUBRAMANI M, KUMAR TR, BABU M: Skin substitutes: a review. Burns (2001) 27(5):534-544.
   PubMed Web of Science ®Google Scholar
• PURDUE GF, HUNT JL, STILL JM et al.: A multicenter clinical trial of a biosynthetic skin replacement, Dermagraft-TC, compared with cryopreserved human cadaver skin for temporary coverage of excised burn wounds. J. Burn Care Rehab. (1997) 18(1 pt 1):52-57.
   PubMedGoogle Scholar
• PURDUE GF: Dermagraft-TC pivotal safety and efficacy study. J. Burn Care Rehab. (1997) 18(1 pt 2):S13-S14.
   Google Scholar
• GENTZKOW GD, IWASAKI SD, HERSHON KS et al.: Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care (1996) 19(4):350-354.
   PubMed Web of Science ®Google Scholar
• FALANGA V, MARGOLIS D, ALVAREZ O et al.: Rapid healing of venous ulcers and lack of clinical rejection with an allogenic cultured human skin equivalent. Arch. Dermatol. (1998) 134(3):293-300.
   PubMed Web of Science ®Google Scholar
• BRISSETT AE, HOM DB: The effects of tissue sealants, platelet gels, and growth factors on wound healing. Curr. Opin. Otolaryngol. Head Neck Surg. (2003) 11(4):245-250.
   PubMedGoogle Scholar
• SIEDENTOP KH, PARK JJ, SHAH AN, BHATTACHARYYA TK, O’GRADY KM: Safety and efficacy of currently available fibrin tissue adhesives. Am. J. Otolaryngol. (2001) 22(4):230-235.
   PubMed Web of Science ®Google Scholar
• STEED DL: Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. J. Vasc. Surg. (1995) 21(1):71-78.
   PubMed Web of Science ®Google Scholar
• ROBSON MC, PHILLIPS LG, THOMASON A, ROBSON LE, PIERCE GF: Platelet-derived growth factor BB for the treatment of chronic pressure ulcers. Lancet (1992) 339:23-25.
   PubMed Web of Science ®Google Scholar
• PIERCE GF, MUSTOE TA, ALTROCK BW, DEUEL TF, THOMASON A: Role of platelet-derived growth factor in wound healing. J. Cell. Biochem. (1991) 45(4):319-326.
   PubMed Web of Science ®Google Scholar
• BEER HD, LONGAKER MT, WERNER S: Reduced expression of PDGF and PDGF receptors during impaired wound healing. J. Invest. Dermatol. (1997) 109(2):132-138.
   PubMed Web of Science ®Google Scholar
• D’HEMECOURT PA, SMIELL JM, KARIM MR: Sodium carboxymethylcellulose aqueous based gel versus becaplermin gel in patients with nonhealing lower extremity diabetic ulcers. Wounds (1998) 10(3):69-75.
   Web of Science ®Google Scholar
• SMIELL JM, WIEMANJ, STEED DL et al.: Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies. Wound Repair Regen. (1999) 7(5):335-346.
   PubMed Web of Science ®Google Scholar
• WIEMAN TJ, SMIELL JM, SU Y: Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. Diabetes Care (1998) 21(5):822-827.
   PubMed Web of Science ®Google Scholar
• SHACKELFORD DP, FACKLER E, HOFFMAN MK, ATKINSON S: Use of topical recombinant human platelet-derived growth factor BB in abdominal wound separation. Am. J. Obstet. Gynecol. (2002) 186(4):701-704.
   PubMed Web of Science ®Google Scholar
• LEGRAND EK: Preclinical promise of becaplermin (rhPDGF-BB) in wound healing. Am. J. Surg. (1998) 176(Suppl. 2A):48S-54S.
   PubMed Web of Science ®Google Scholar
• HENRY G, GARNER WL: Inflammatory mediators in wound healing. Surg. Clin. N. Am. (2003) 83(3):483-507.
   PubMed Web of Science ®Google Scholar
• GROVES RW, SCHMIDT-LUCKE JA: Recombinant human GM-CSF in the treatment of poorly healing wounds. Adv. Skin Wound Care (2000) 13(3 part 1):107-112.
   PubMedGoogle Scholar
• DA COSTA RM, RIBEIRO JESUS FM, ANICETO C, MENDES M: Randomized, double-blind, placebo-controlled, dose-ranging study of granulocyte-macrophage colony stimulating factor in patients with chronic venous leg ulcers. Wound Repair Regen. (1999) 7(1):17-25.
   PubMed Web of Science ®Google Scholar
• JYUNG R, WU L, PIERCE GF, MUSTOE TA: Granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor: differential action on incisional wound healing. Surgery (1994) 115(3):325-334.
   PubMed Web of Science ®Google Scholar
• MALIK IA, ZAHID M, HAQ S, SYED S, MOID I, WAHEED I: Effect of subcutaneous injection of granulocyte-macrophage colony-stimulating factor (GM-CSF) on healing of chronic refractory wounds. Eur. J. Surg. (1998) 164(10):737-744.
   PubMedGoogle Scholar
• SENET P, MONS B, ARACTANGI S, TILLEUL P: Evaluation of the stability and efficacy of rhGM-CSF as a topical agent in a gel formulation. J. Wound Care (2002) 11(4):132-134.
   PubMedGoogle Scholar
• URE I, PARTSCH B, WOLFF K, PETZELBAUER P: Granulocyte/macrophage colony-stimulating factor increases wound-fluid interleukin 8 in normal subjects but does not accelerate wound healing. Br. J. Dermatol. (1998) 138(2):277-282.
   PubMed Web of Science ®Google Scholar
• JORGENSEN LN, AGREN MS, MADSEN SM et al.: Dose-dependent impairment of collagen deposition by topical granulocyte-macrophage colony-stimulating factor in human experimental wounds. Ann. Surg. (2002) 236(5):684-692.
   PubMed Web of Science ®Google Scholar
• RUMALLA VK, BORAH GL: Cytokines, growth factors and plastic surgery. Plast. Reconstr. Surg. (2001) 108(3):719-733.
   PubMed Web of Science ®Google Scholar
• HEBDA PA, KLINGBEIL CK, ABRAHAM JA, FIDDES JC: Basic fibroblast growth factor stimulation of epidermal wound healing in pigs. J. Invest. Dermatol. (1990) 95(6):626-631.
   PubMed Web of Science ®Google Scholar
• HAYWARD P, HOKANSON J, HEGGERS J et al.: Fibroblast growth factor reverses the bacterial retardation of wound contraction. Am. J. Surg. (1992) 163:288-293.
   PubMed Web of Science ®Google Scholar
• UHL E, BARKER JH, BONDAR I et al.: Basic fibroblast growth factor accelerates wound healing in chronically ischaemic tissue. Br. J. Surg. (1993) 80(8):977-980.
   PubMed Web of Science ®Google Scholar
• WU L, PIERCE GF, GALIANO RD, MUSTOE TA: Keratinocyte growth factor induces granulation tissue in ischemic dermal wounds. Importance of epithelial-mesenchymal interactions. Arch. Surg. (1996) 131(6):660-666.
   PubMed Web of Science ®Google Scholar
• ROBSON MC, PHILLIPS TJ, FALANGA V et al.: Randomized trial of topically applied repifermin (recombinant human keratinocyte growth factor-2) to accelerate wound healing in venous ulcers. Wound Repair Regen. (2001) 9(5):347-352.
   PubMed Web of Science ®Google Scholar
• JIMINEZ PA, RAMPY MA: Keratinocyte growth factor-2 accelerates wound healing in incisional wounds. J. Surg. Res. (1999) 81(2):238-242.
   PubMed Web of Science ®Google Scholar
• SPIELBERGER R, STIFF P, BENSINGER W et al.: Palifermin for oral mucositis after intensive therapy for hematologic cancers. N. Engl. J. Med. (2004) 351:2590-2598.
   PubMed Web of Science ®Google Scholar
• SEN CK, KHANNA S, VENOJARVI M et al.: Copper-induced vascular endothelial growth factor expression and wound healing. Am. J. Physiol. Heart Circ. Physiol. (2002) 282(5):H1821-H1827.
   PubMed Web of Science ®Google Scholar
• WERNER S, GROSE R: Regulation of wound healing by growth factors and cytokines. Physiol. Rev. (2003) 83(3):835-870.
   PubMed Web of Science ®Google Scholar
• LAUER G, SOLLBERG S, COLE M et al.: Expression and proteolysis of vascular endothelial growth factor is increased in chronic wounds. J. Invest. Dermatol. (2000) 115(1):12-18.
   PubMed Web of Science ®Google Scholar
• CORRAL CJ, SIDDIQUI A, WU L, FARRELL CL, LYONS D, MUSTOE TA: Vascular endothelial growth factor is more important than basic fibroblast growth factor during ischemic wound healing. Arch. Surg. (1999) 134(2):200-205.
   PubMed Web of Science ®Google Scholar
• MALINDA KM, SIDHU GS, MANI H et al.: Thymosin-β4 accelerates wound healing. J. Invest. Dermatol. (1999) 113(3):364-368.
   PubMed Web of Science ®Google Scholar
• PHILIP D, GOLDSTEIN AL, KLEINMAN HK: Thymosin-β4 promotes angiogenesis, wound healing, and hair follicle development. Mech. Ageing Develop. (2004) 125(2):113-115.
   PubMed Web of Science ®Google Scholar
• PHILIP D, BADAMCHIAN M, SCHEREMETA B, NGUYEN M, GOLDSTEIN AL, KLEINMAN H: Thymosin-β4 and a synthetic peptide containing its actin-binding domain promote dermal wound repair in db/db diabetic mice and in aged mice. Wound Repair Regen. (2003) 11(1):19-24.
   PubMed Web of Science ®Google Scholar
• BROWN GL, NANNEY LB, GRIFFEN J et al.: Enhancement of wound healing by topical treatment with epidermal growth factor. N. Engl. J. Med. (1989) 321:76-79.
   PubMed Web of Science ®Google Scholar
• TSANG MW, WONG WKR, HUNG CS, LAI KM, TANG W, CHEUNG EYN: Human epidermal growth factor enhances healing of diabetic foot ulcers. Diabetes Care (2003) 26(6):1856-1861.
   PubMed Web of Science ®Google Scholar
• SHAH M, FOREMAN DM, FERGUSON MWL: Neutralisation of TGF-β1 and TGF-β2 or exogenous addition of TGF-β3 to cutaneous rat wounds reduces scarring. J. Cell. Sci. (1995) 108(3):985-1002.
   PubMed Web of Science ®Google Scholar
• ROBSON MC, PHILLIPS LG, COOPER DM et al.: Safety and effect of TGF-β2 for treatment of venous stasis ulcers. Wound Repair Regen. (1995) 3(2):157-167.
   PubMedGoogle Scholar
• HIRSHBERG J, COLEMAN J, MARCHANT B, REES RS: TGF-β3 in the treatment of pressure ulcers: a preliminary report. Adv. Skin Wound Care (2001) 14(2):91-95.
   PubMedGoogle Scholar
• DAVIDSON JM, KRIEG T, EMING SA: Particle-mediated gene therapy of wounds. Wound Repair Regen. (2000) 8(6):452-459.
   PubMed Web of Science ®Google Scholar
• PIERCE GF, TARPLEY JE, TSENG J et al.: Detection of platelet-derived growth factor (PDGF)-AA in actively healing human wounds treated with recombinant PDGF-BB and absence of PDGF in chronic nonhealing wounds. J. Clin. Invest. (1995) 96(3):1336-1350.
   PubMed Web of Science ®Google Scholar
• CHANDLER LA, GU DL, MA C et al.: Matrix-enabled gene transfer for cutaneous wound repair. Wound Repair Regen. (2000) 8(6):473-479.
   PubMed Web of Science ®Google Scholar
• YAO F, ERIKSSON E: A novel tetracycline-inducible viral replication switch. Gene Ther. (1999) 10(3):419-427.
   Web of Science ®Google Scholar
• NANNEY LB, PAULSEN S, DAVIDSON MK, CARDWELL NL, WHITSITT JS, DAVIDSON JM: Boosting epidermal growth factor receptor expression by gene gun transfection stimulates epidermal growth in vivo. Wound Repair Regen. (2000) 8(2):117-127.
   PubMed Web of Science ®Google Scholar
• ERIKSSON E: Gene transfer in wound healing. Adv. Skin Wound Care (2000) 13(Suppl. 2):20-22.
   PubMedGoogle Scholar
• LINDBLAD WI: Gene therapy in wound healing – 2000: a promising future. Wound Repair Regen. (2000) 8(6):441-442.
   PubMed Web of Science ®Google Scholar
• HART J, SILCOCK D, GUNNIGLE S, CULLEN B, LIGHT ND, WATT PW: The role of oxidized regenerated cellulose/collagen in wound repair: effects in vitro on fibroblast biology and in vivo in a model of compromised healing. Int. J. Biochem. Cell. Bio. (2002) 34(12):1557-1570.
   PubMed Web of Science ®Google Scholar
• CULLEN B, WATT PW, LUNDQVIST C et al.: The role of oxidized regenerated cellulose/collagen in chronic wound repair and its potential mechanism of action. Int. J. Biochem. Cell. Bio. (2002) 34(12):1544-1556.
   PubMed Web of Science ®Google Scholar
• DIGNASS AU, BECKER A, SPIEGLER S, GOEBELL H: Adenine nucleotides modulate epithelial wound healing in vitro. Eur. J. Clin. Invest. (1998) 28(7):554-561.
   PubMed Web of Science ®Google Scholar
• MONTESINOS MC, GADANGI P, LONGAKER M et al.: Wound healing is accelerated by agonists of adenosine A2 (G α s-linked) receptors. J. Exp. Med. (1997) 186(9):1615-1620.
   PubMed Web of Science ®Google Scholar
• VICTOR-VEGA C, DESAI A, MONTESINOS MC, CRONSTEIN BN: Adenosine A2A receptor agonists promote more rapid wound healing than recombinant human platelet-derived growth factor (Becaplermin Gel). Inflammation (2002) 26(1):19-24.
   PubMed Web of Science ®Google Scholar
• MONTESINOS MC, SHAW JP, YEE H, SHAMAMIAN P, CRONSTEIN BN: Adenosine A2A receptor activation promotes wound neovascularization by stimulating angiogenesis and vasculogenesis. Am. J. Path. (2004) 164(6):1887-1892.
   PubMed Web of Science ®Google Scholar
• ASHCROFT GS, GREENWELL-WILD T, HORAN MA, WAHL SM, FERGUSON MWJ: Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response. Am. J. Path. (1999) 155:1137-1146.
   PubMed Web of Science ®Google Scholar
• ASHCROFT GS, DODSWORTH J, VAN BOXTEL E et al.: Estrogen accelerates cutaneous wound healing associated with an increase in TGF-β1 levels. Nat. Med. (1997) 3(11):1209-1215.
   PubMed Web of Science ®Google Scholar
• TRENT JT, KIRSNER RS: Leg ulcers in sickle cell disease. Adv. Skin Wound Care (2004) 17(8):410-416.
   PubMedGoogle Scholar
• ANG E, LEE ST, GAN CS, CHAN YH, CHEUNG YB, MACHIN D: Pain control in a randomized, controlled, clinical trial comparing moist exposed burn ointment and conventional methods in patients with partial-thickness burns. J. Burn Care Rehab. (2003) 24(5):289-296.
   PubMedGoogle Scholar
• AIT-AISSA M: Advances in the use of MEBO (a new approach in the method of application). Annals of Burns and Fire Disasters (2002) 15(1).
   Google Scholar
• ATIYEH BS, EL-MUSA KA, DHAM R: Scar quality and physiologic barrier function restoration after moist and moist-exposed dressings of partial-thickness wounds. Dermatol. Surg. (2003) 29(1):14-20.
   PubMed Web of Science ®Google Scholar
• ZHANG HQ, YIP TP, HUI I, LAI V, WONG A: Efficacy of moist exposed burn ointment on burns. J. Burn Care Rehab. (2005) 26(3):247-251.
   PubMedGoogle Scholar
• ATIYEH BS, AMM CA, EL-MUSA KA: Improved scar quality following primary and secondary healing of cutaneous wounds. Aesthetic Plast. Surg. (2003) 27(5):411-417.
   PubMed Web of Science ®Google Scholar
• ROBSON MC: Impediments to drug development. Wound Repair Regen. (2003) 11(3):161-165.
   PubMed Web of Science ®Google Scholar